US FDA authorizes sale of four menthol e-cigarette products by Altria's NJOY, potentially boosting Altria's revenue growth.

Altria Group stock may benefit as its NJOY business gains momentum after the US FDA authorized the sale of four menthol e-cigarette products. The positive news follows the FDA's tough stance on tobacco products, particularly flavored ones. NJOY's refillable pod products and disposable e-cigarette products received approval, which could boost Altria's revenue growth, currently struggling over the past two years.

June 29, 2024
3 Articles